Cieuta-Walti, C., Cuenca Royo, A. M., Langohr, K., López-Vílchez, M. Á., García García, J., Aldea-Perona, A., . . . Group, P. S. (2022). Safety and preliminary efficacy on cognitive performance and adaptive functionality of epigallocatechin gallate (EGCG) in children with Down syndrome. A randomized phase Ib clinical trial (PERSEUS study).
Citación estilo ChicagoCieuta-Walti, Cécile, et al. Safety and Preliminary Efficacy On Cognitive Performance and Adaptive Functionality of Epigallocatechin Gallate (EGCG) in Children With Down Syndrome. A Randomized Phase Ib Clinical Trial (PERSEUS Study). 2022.
Cita MLACieuta-Walti, Cécile, et al. Safety and Preliminary Efficacy On Cognitive Performance and Adaptive Functionality of Epigallocatechin Gallate (EGCG) in Children With Down Syndrome. A Randomized Phase Ib Clinical Trial (PERSEUS Study). 2022.